miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
18434550 Alzheimer disease, susceptibility to - 104300 Neurological cerebral cortex miRNA downregulation - 1.32 - Patient study phenotype-control miRNA microarray
16934749 Cancer - 0 (Leukemia, acute lymphoblastic - 0) Cancer JURKAT cell miRNA overexpression - - - Cell culture study Northern Blot
17178851 Leukemia, chronic lymphatic, susceptibility to - 151400 Cancer blood miRNA overexpression - 1.69 - Patient study phenotype-phenotype miRNA microarray
17178851 Leukemia, chronic lymphatic, susceptibility to - 151400 Cancer blood miRNA overexpression - 3.15 - Patient study phenotype-phenotype miRNA microarray
17178851 Leukemia, chronic lymphatic, susceptibility to - 151400 Cancer blood miRNA downregulation - - - Patient study phenotype-phenotype miRNA microarray
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 4.09 - Patient study phenotype-control miRNA microarray
18766170 Lung cancer - 211980 Cancer serum miRNA downregulation - 4.54545 - Patient study phenotype-control deep sequencing
19074725 Cancer - 0 (Macroglobulinemia, Waldenstrom - 0) Cancer bone marrow miRNA overexpression - - - Patient study phenotype-control miRNA microarray
18647411 - - hematopoietic stem cell miRNA overexpression - 1.92 - Bioprocess study miRNA microarray
19074725 Cancer - 0 (Macroglobulinemia, Waldenstrom - 0) Cancer bone marrow miRNA overexpression - - - Patient study phenotype-control miRNA microarray
18791127 Gastrointestinal - 0 (Hepatitis-B-virus (HBV)-related cirrhosis - 0) Gastrointestinal spleen miRNA overexpression - - - Patient study phenotype-control miRNA microarray